What the Options Market Tells Us About Novo Nordisk
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
Aurisco Pharmaceutical (605116.SH): Currently, there is no collaboration with Novo-Nordisk A/S.
On November 28, Glonghui reported that aurisco pharmaceutical (605116.SH) stated on the investor interaction platform that the company is actively developing the market for the active pharmaceutical ingredient semaglutide, and currently has no collaboration with novo-nordisk a/s.
Sector Update: Health Care Stocks Advance Wednesday Afternoon
LLY, NVO Stock Up as Biden Proposes Medicare Cover for Obesity Drugs
Novo Nordisk, KKR Joint Acquisition of Sylvan Gets EU Greenlight
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
a bit late with my European Morning News see post ...
